Drug Approval | November 19, 2022
Strides receives USFDA approval for Potassium Chloride Oral Solution
The approval further strengthens the Potassium Chloride franchise for the company.
The approval further strengthens the Potassium Chloride franchise for the company.
The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
Plans to double its manufacturing footprint to bolster the growth
Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
This includes Madhurodhi, HBP Care & LBP Care for sugar & BP patients
Pfizer’s Paxlovid is approved by US FDA for COVID treatment
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Naproxen Sodium Capsules, 220 mg, of Bionpharma
Subscribe To Our Newsletter & Stay Updated
